Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Genetic Assessment of Dopamine Agonist-Induced Impulse Control Disorder in Patients With Prolactinoma

9 Dec 2022

Abstract excerpt

CONTEXT: Dopamine agonist (DA)-induced impulse control disorder (ICD) represents a group of behavioral disorders that are increasingly recognized in patients with prolactinoma. OBJECTIVE: We aimed to examine the genetic component of the underlying mechanism of DA-induced ICD. METHODS: Patients with prolactinoma receiving dopamine agonist (cabergoline) treatment were included in the study. These patients were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal and Paraganglionic Tumors
Share to Neurotransmitter Receptor Influence on Behavior
Share to Pituitary Gland Disorders and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36494095
DOI: 10.1210/clinem/dgac718

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Genetic Assessment of Dopamine Agonist-Induced Impulse Control Disorder in Patients With ProlactinomaPMID 36494095Read ↗

Dopamine D3 receptor Ser9Gly variant is associated with impulse control disorders in Parkinson's disease patients.Semantic proximity Read ↗

Current Data on the Genetic Background of Impulse Control Disorders in Parkinson’s DiseaseSemantic proximity Read ↗

Clinical-genetic model predicts incident impulse control disorders in Parkinson's disease.Semantic proximity Read ↗

Integrating genetic and clinical data to predict impulse control disorders in Parkinson's disease.Semantic proximity Read ↗

Impulse control disorder: Review on clinical, pharmacologic, and genetic risk factors.Semantic proximity Read ↗

Dopamine genetic risk scores and psychiatric symptoms: Interacting risk factors for impulse control behaviours in de novo Parkinson's disease.Semantic proximity Read ↗

Candidate Genes Encoding Dopamine Receptors as Predictors of the Risk of Antipsychotic-Induced Parkinsonism and Tardive Dyskinesia in Schizophrenic PatientsSemantic proximity Read ↗

DRD4 Gene polymorphism and impulse control disorder induced by dopamine agonists in Parkinson's disease.Semantic proximity Read ↗

Dopaminergic and Opioid Pathways Associated with Impulse Control Disorders in Parkinson’s DiseaseSemantic proximity Read ↗

Cabergoline and prolactinomas: lack of association between DRD2 polymorphisms and response to treatment.Semantic proximity Read ↗

Pharmacogenetics of D2 dopamine receptor gene in prolactin-secreting pituitary adenomas.Semantic proximity Read ↗

Clinical and Clinical-Pharmacogenetic Models for Prediction of the Most Common Psychiatric Complications Due to Dopaminergic Treatment in Parkinson's Disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.